2025-523536-39-00招募中1 期
A Phase 1 Study of TT125-802 as Monotherapy and in Combination with Pomalidomide and Dexamethasone in Participants with Multiple Myeloma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Chief Executive Officer
Scientific
TOLREMO therapeutics AG
研究点 (5)
Loading locations...
相似试验
已完成
3 期
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescent and adult patients with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.2023-508013-16-00CCDRD Cooperative Clinical Drug Research and Development AG, Inmunotek S.L., ClinCompetence Cologne GmbH600
已完成
不适用
Double-blind comparative trial of TP-1222jRCT2051260093360
进行中（未招募）
2 期
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposureLyme DiseaseNCT07562087Tarsus Pharmaceuticals, Inc.722
招募中
2 期
Phase 2 Trial of TAK-755 for Acute Ischemic StrokeAcute Ischemic Stroke2025-522734-31-00Takeda Development Center Americas Inc.67
尚未招募
1 期
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid TumorsUrological CancerSolid CancerNCT07744243Sichuan Baili Pharmaceutical Co., Ltd.30